Micardis Hct Tablet
Product Images NDC 0597-0044

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Micardis Hct (NDC 0597-0044). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Boehringer Ingelheim Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Micardis 01

FDA Label Image

Micardis 02

FDA Label Image

Micardis 03

FDA Label Image

Micardis 04

FDA Label Image

Micardis 05

FDA Label Image

Micardis 06

FDA Label Image

Micardis 07

This text is a product label for Micardis HCT tablets. It contains information regarding the dosage, ingredients and manufacturer of the tablets. It also provides guidance on storage and administration. Finally, there is a QR code which can be scanned for further product information or there is a phone number for Boehringer Ingelheim Pharmaceuticals, Inc. for prescribing information.*

FDA Label Image

Micardis 08

Micardise HCT is a medication in tablet form that contains both telmisartan and hydrochlorothiazide. It comes in a container that has three blister cards with ten tablets each, for a total of 30 tablets. It is important to note that the tablets are moisture-sensitive and should not be removed from the blister until immediately before taking. Dosage information should be read carefully, and the medication should be kept out of reach of children. For more information or to obtain prescribing information, call Boehringer Ingelheim Pharmaceuticals, Inc. at 1-800-562-6257.*

FDA Label Image

Micardis 09

Micardis HCT is a medicine containing telmisartan and hydrochlorothiazide used to treat high blood pressure. The package contains 30 tablets, 3 blister cards of 10 tablets each, with a strength of 80mg/25mg. The tablets are moisture-sensitive and not to be removed from the blisters until immediately before administration. The manufacturer is Boehringer Ingelheim Pharmaceuticals, Inc. The package has a National Drug Code of 0597-0042-37. Refer to accompanying prescribing information for dosage instructions.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.